Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the safety, effectiveness, pharmacokinetics and pharmacodynamics of anastrozole (ARIMIDEX™) in the treatment of boys with gynecomastia.


Clinical Trial Description

n/a


Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00241436
Study type Interventional
Source AstraZeneca
Contact
Status Completed
Phase Phase 2
Start date June 2005
Completion date November 2006

See also
  Status Clinical Trial Phase
Completed NCT05093049 - Renuvion APR System When Used as an Adjunct Procedure In Gynecomastia Surgery N/A
Completed NCT03319862 - Post-massive Weight Loss Chest Contouring: Inferior Pedicle Technique in Pseudo-gynecomastia Correction N/A
Withdrawn NCT02711605 - UltraShape Device for Non-Invasive Fat Reduction in the Male Breast (Pseudogynecomastia) N/A
Completed NCT04425447 - Thoracic Interfascial Plane Block Versus Thoracic Paravertebral Block in Gynecomastia Surgery N/A
Completed NCT00637182 - Gynecomastia Extension Study Phase 3
Recruiting NCT04836364 - Skincare Products and Environmental Health
Active, not recruiting NCT04966078 - Treatment of Mild and Moderate Cases of Gynaecomastia N/A
Completed NCT04063722 - Modified Benelli Procedure For Subcutaneous Mastectomy N/A
Not yet recruiting NCT06070324 - Effect of Suture Material on Postoperative Nipple Areolar Complex Widening N/A
Recruiting NCT01791660 - Targeted Fat Reduction of Pseudogynecomastia in the Male Breast Using the ZELTIQ Coolsculpting System N/A
Withdrawn NCT04321967 - Nitropaste in Breast Reduction Phase 3